Inhibiting cholesterol-associated protein reduces high-risk blockages in arteries

"Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes. The study recently appeared online in Nature Medicine" - ScienceDaily